1. Homepage
  2. Equities
  3. Canada
  4. Toronto Stock Exchange
  5. Sernova Corp.
  6. News
  7. Summary
    SVA   CA81732W1041

SERNOVA CORP.

(SVA)
  Report
End-of-day quote Toronto Stock Exchange  -  2022-08-11
1.160 CAD   +0.87%
08/12Evotec SE reports results for the first half-year 2022 and provides corporate updatesHamburg, Germany
AQ
07/29SERNOVA : Investor Presentation - August 2022
PU
07/05SERNOVA : Investor Presentation - July 2022
PU
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Sernova Corp. Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2022

06/27/2022 | 06:34pm EDT

Sernova Corp. reported earnings results for the second quarter and six months ended April 30, 2022. For the second quarter, the company reported net loss was CAD 4.92 million compared to CAD 1.67 million a year ago. Basic loss per share from continuing operations was CAD 0.02 compared to CAD 0.01 a year ago. For the six months, net loss was CAD 10.38 million compared to CAD 3.16 million a year ago. Basic loss per share from continuing operations was CAD 0.04 compared to CAD 0.02 a year ago.


© S&P Capital IQ 2022
All news about SERNOVA CORP.
08/12Evotec SE reports results for the first half-year 2022 and provides corporate updatesHa..
AQ
07/29SERNOVA : Investor Presentation - August 2022
PU
07/05SERNOVA : Investor Presentation - July 2022
PU
06/27SERNOVA : Q2 2022 md&a
PU
06/27SERNOVA : Q2 2022 fs
PU
06/27Sernova Corp. Reports Earnings Results for the Second Quarter and Six Months Ended Apri..
CI
06/15SERNOVA : to Participate in the Truist Securities Cell Therapy Symposium, Symposia-cel in ..
PU
06/07Sernova Corp. Announces Positive Updated Phase 1/2 Clinical Data on Cell Pouch System T..
CI
06/06Sernova Announces Positive Updated Phase 1/2 Clinical Data on Cell Pouch System™ ..
AQ
2016SERNOVA : to Present at the Biotech Showcase(TM) 2016 in San Francisco on January 13, 2016
MW
More news
Financials
Sales 2022 - - -
Net income 2022 -18,8 M -14,7 M -14,7 M
Net Debt 2022 - - -
P/E ratio 2022 -15,5x
Yield 2022 -
Capitalization 321 M 251 M 251 M
Capi. / Sales 2022 -
Capi. / Sales 2023 -
Nbr of Employees -
Free-Float 97,5%
Chart SERNOVA CORP.
Duration : Period :
Sernova Corp. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SERNOVA CORP.
Short TermMid-TermLong Term
TrendsNeutralNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 4
Last Close Price 1,16 CAD
Average target price 4,01 CAD
Spread / Average Target 246%
EPS Revisions
Managers and Directors
Philip M. Toleikis President, Chief Executive Officer & Director
David Swetlow Chief Financial Officer
Frank A. Holler Chairman
Delfina Siroen Senior Director-Research & Development
Frank Shannon Vice President-Clinical & Regulatory
Sector and Competitors
1st jan.Capi. (M$)
SERNOVA CORP.-36.26%251
STRYKER CORPORATION-16.57%84 411
SMITH & NEPHEW PLC-18.52%11 104
INSPIRE MEDICAL SYSTEMS, INC.-4.39%6 300
AXONICS, INC.29.25%3 556
GLAUKOS CORPORATION13.37%2 397